Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC
Go back to Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC| StemCells, Inc. (NASDAQ: TEM) | Delayed: 63.81 -3.95 (5.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.76 | 52 Week High | $0.45 | |||
| Open | $66.10 | 52 Week Low | $0.37 | |||
| Day High | $68.29 | P/E | N/A | |||
| Day Low | $61.51 | EPS | $-0.31 | |||
| Volume | 6,179,686 | |||||



